Summit Therapeutics (SMMT) Asset Utilization Ratio (2020 - 2023)

Summit Therapeutics' Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.0 for Q2 2023.

• Quarterly Asset Utilization Ratio fell 95.36% year-over-year to 0.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 0.0 (down 95.36% YoY) and the FY2022 annual result came in at 0.0, down 89.18% from the prior year.
• Asset Utilization Ratio was 0.0 for Q2 2023 at Summit Therapeutics, down from 0.0 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.02 in Q2 2022 and bottomed at 0.0 in Q2 2023.
• A 4-year average of 0.01 and a median of 0.01 in 2022 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 348.67% — and 2023, when it tumbled 95.36%.
• Summit Therapeutics' Asset Utilization Ratio stood at 0.01 in 2020, then surged by 38.49% to 0.01 in 2021, then sank by 88.49% to 0.0 in 2022, then sank by 48.05% to 0.0 in 2023.
• Business Quant data shows SMMT's Asset Utilization Ratio at 0.0 in Q2 2023, 0.0 in Q1 2023, and 0.0 in Q4 2022.